Skip to content

DrugPatentWatch - Make Better Decisions

Blog Home
DrugPatentWatch Home
Plans & Pricing
About
Contact

DrugPatentWatch - Make Better Decisions

Blog Home
DrugPatentWatch Home
Plans & Pricing
About
Contact

Figure 1 – Overview of process to repurpose existing drugs for cancer indications

Leave a Comment / By DrugPatentWatch / July 28, 2018

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at

Related Posts:

Comparison of Sales Income and Research and…
Tracking 20 Years of Compound-to-Target Output from…
Giving Drugs a Second Chance: Overcoming Regulatory…
Overcoming Regulatory and Financial Hurdles in…
A Comprehensive Map of FDA-Approved Pharmaceutical Products
Drug Repurposing: An Overview
CDCDB: A large and continuously updated drug…
Artificial intelligence in drug discovery: what is…
Using clinical trial information to forecast future…
The Biosimilar Landscape: An Overview of Regulatory…
Review of Drugs Approved via the 505(b)(2) Pathway:…
Exploring Drug Repositioning Approaches and Resources
Ten years of biosimilars in Europe: development and…
Measuring the knowledge translation and convergence…
List of NIH-Licensed Technologies
The Role of Artificial Intelligence (AI) and Machine…
The 505(b)(2) Drug Patent Approval Process: Uses and…
Differences in rates of switchbacks after switching…
Development of the generic drug industry in the US…
Measuring the effectiveness and impact of an open…
Market access of gene therapies across Europe, USA,…
Affordability and availability of off-patent drugs…
How is biotech combating these five killer diseases…
Ideation and implementation of an open science drug…

Post navigation

Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics

Get Email Updates

Email

Expiring Drug Patent Cheatsheet

Get the cheat sheet

Make Better Decisions

See Plans & Pricing

Recent Posts

Addressing supply chain challenges for biosimilar products
Key Considerations for Generic Drug Stability Testing
Conducting a Biopharmaceutical Freedom-to-Operate (FTO) Analysis: Key Considerations for Generic Drug Stability Testing
The Patent Playbook for Pharma: Protect Your Drug. Protect Your Profits.
The Impact of Technological Advances on Generic Drug Development

Popular Posts

Drug Patent Life: The Complete Guide to Pharmaceutical Patent Duration and Market Exclusivity
Top 6 issues facing the biotechnology industry
Valuation of Pharmaceutical Companies: A Comprehensive Analysis of Key Considerations
Viagra: A Complicated Case Study of Generic Drug Market Entry in the United States
Comprehensive Guide to Pharmaceutical Portfolio Management: Essential Reading Resources
Top Strategies for Pharma Profitability after Drug Patents Expire
First Generic Launch has Significant First-Mover Advantage Over Later Generic Drug Entrants
How Premarin Maintained Market Dominance Without Patent Protection
How long does a patent last for drugs?
Addressing supply chain challenges for biosimilar products

Copyright © 2025 DrugPatentWatch - Make Better Decisions

DrugPatentWatch - Make Better Decisions

Subscribe to Free Updates3,000+ other biopharma execs get our Drug Patent Expiration Alerts. You should too!

Get fresh news and insights, drug patent expirations & more…

EmailEnter your email address

Thanks, I’m not interested